Antiphospholipid syndrome: What’s new in understanding antiphospholipid antibody-related stroke? Joan T. Merrill Invited Commentary Pages: 159 - 161
Treatment of refractory polymyositis and dermatomyositis Steven R. Ytterberg OriginalPaper Pages: 167 - 173
Differential diagnosis of idiopathic inflammatory myopathies Alan N. Baer OriginalPaper Pages: 178 - 187
Pathogenesis of idiopathic inflammatory myopathies Cecilia GrundtmanIngrid E. Lundberg OriginalPaper Pages: 188 - 195
Does diet contribute to the development of hyperuricemia? Susan J. LeeRobert A. Terkeltaub Clinical Trials Report Pages: 207 - 208
Innate immunity in triggering and resolution of acute gouty inflammation David M. RoseRu Liu-Bryan OriginalPaper Pages: 209 - 214
New developments in the epidemiology and genetics of gout Raihana ZakaCharlene J. Williams OriginalPaper Pages: 215 - 223
New developments in clinically relevant mechanisms and treatment of hyperuricemia Susan J. LeeRobert A. Terkeltaub OriginalPaper Pages: 224 - 230
Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis Lauren M. PachmanAdele L. Boskey OriginalPaper Pages: 236 - 243